EquityZen Growth Technology Fund LLC - Series 1493
Raised
$562K
Investors
20
Min Invest
$10,013
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1493 is a Delaware SPV filed by EquityZen Advisors on 2022-11-22, raising $562K from 20 investors under Rule 506(b) and 3(c)(1) exemptions. The vehicle requires a $10K minimum investment and is part of the EquityZen platform, which operates 1889+ related entities facilitating pre-IPO secondary market transactions.
This pre-IPO fund vehicle uses the standard 506(b)/3(c)(1) exemption pairing typical of private secondary market funds, with a $10K minimum positioning it for accredited retail access. The $28K average commitment across 20 investors reflects EquityZen's single-company SPV model, where investors pool capital for exposure to specific late-stage private companies.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.